IOVANCE BIOTHERAPEUTICS INC (IOVA) Stock Income Statement
NASDAQ:IOVA - Nasdaq - US4622601007 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 212.68M | 164.07M | 1.19M | 0.00 | 0.00 | |||
| Cost Of Goods | 166.47M | 124.00M | 10.76M | N/A | N/A | |||
| Gross Profit | 46.20M | 40.08M | -9.57M | N/A | N/A | |||
| Operating Expenses | 437.58M | 427.95M | 450.99M | 398.88M | 342.70M | |||
| Research and Development | 274.43M | 277.34M | 344.08M | 294.78M | 259.04M | |||
| Selling, General, and Administrative Expenses | 163.15M | 150.62M | 106.92M | 104.10M | 83.66M | |||
| Operating Income | -391.38M | -387.88M | -460.56M | -398.88M | -342.70M | |||
| Interest Income/Expense | 20.16M | 20.27M | 13.04M | 2.99M | 450.00K | |||
| Non Recurring Items | N/A | -7.40M | N/A | N/A | N/A | |||
| Income Before Taxes | -378.62M | -375.00M | -447.52M | -395.89M | -342.25M | |||
| Income Tax | -3.26M | -2.83M | -3.48M | N/A | N/A | |||
| Net Income | -375.36M | -372.18M | -444.04M | -395.89M | -342.25M | |||
| EBITDA | -357.62M | -354.71M | -439.14M | -389.57M | -339.59M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.23 | -1.28 | -1.89 | -2.49 | -2.23 | |||
| Non GAAP EPS | -1.24 | -1.30 | -1.88 | -2.48 | -2.22 | |||
| Statistics | ||||||||
| Gross Profit Margin | 21.72% | 24.43% | -804.54% | N/A | N/A | |||
| Profit Margin | -176.49% | -226.84% | -37345.42% | N/A | N/A | |||
| Operating Profit Margin | -184.02% | -236.41% | -38734.99% | N/A | N/A | |||
All data in USD